A Clinical Method For Mapping And Quantifying Blood Stasis And Thrombus Risk In The Heart
- Technology Application
- This technology is patent pending and realized in a demonstrated software package with a small set of patient data supporting efficacy. This technology could be suitable as a software services business and/or an add-on tool for an existing clinical imaging platform.
- Detailed Technology Description
- Given here is an enhanced imaging technique to evaluate a patient’s risk for Stroke based upon quantifiable measures of blood stasis (residence time) in the Left Ventricle. The method is realized in software and leverages existing clinically abundant ultra-sound equipment to provide a clear measure of a patient’s risk factors for a future Stroke based upon present measurements acquired in the clinic. Leveraging this diagnostic, more informed decisions can be made regarding the prescription of blood-thinners, potentially leading to a personalized medicine approach where a diagnostic such as this becomes a requirement before subjecting someone to a lifetime of expensive and risky anti-coagulant therapy.
- Application No.
- 20170150928
- Others
-
Related Materials
Tech ID/UC Case
25745/2016-003-0
Related Cases
2016-003-0
- *Abstract
-
Market:
Approximately 5 million people in the US currently suffer from congestive heart failure. Of these, approximately 50% have left ventricular (LV) systolic dysfunction (weak heart muscle) and have a 5x increased risk for Stroke.
- *IP Issue Date
- Jun 1, 2017
- *Principal Investigator
-
Name: Raquel Alvarez
Department:
Name: Javier Bermejo
Department:
Name: Juan del Alamo
Department:
Name: Andrew Kahn
Department:
Name: Pablo Martínez-Legazpi
Department:
Name: Lorenzo Rossini
Department:
- Country/Region
- USA
For more information, please click Here
